Abogen, Inc
At AboGen, we believe that drawing large volumes of blood using invasive needles for research and diagnostic purposes does not fit with the 21st century. Founded in 2012, AboGen Inc. is the world's first company to show, through various independent 3rd party validators, that its technology can allow for the use of saliva, instead of blood, for various cell based research and diagnostic applications, including serological and genetic. We do not plan on replacing blood completely but we do plan on elevating saliva, as an alternative to blood for various cell based diagnostic applications, ABOve and beyond GENetic applications.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Abogen, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Abogen, Inc
2 distinct titles indexed · top 2 shown.
- 1chief innovation officer
- 1research assistant
Sign up to unlock all 2 contacts at Abogen, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Abogen, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.